Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 12.738\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1cc(C)n(CCC(=O)Nc2ccc(-c3ccno3)cc2)n1
b. CC(NC(=O)c1ccc(Br)cc1)C(=O)NC1=NCCS1
c. Cn1c(=O)cc(Nc2ccccc2)c2c(=O)n(-c3ccccc3)c(=O)n(-c3ccccc3)c21
Answer: b. CC(NC(=O)c1ccc(Br)cc1)C(=O)NC1=NCCS1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(NC(=O)c1ccc(Br)cc1)C(=O)NC1=NCCS1
CC(NC(=O)c1ccc(Br)cc1)C(=O)NC1=NCCS1
4-bromo-N-[1-(4,5-dihydro-1,3-thiazol-2-ylamino)-1-oxopropan-2-yl]benzamide